当前位置:主页 > 医学论文 > 眼科论文 >

螨过敏咽炎患者舌下脱敏的疗效及其影响因素分析

发布时间:2018-07-31 18:05
【摘要】:目的:评估舌下特异性免疫治疗(SLIT)螨过敏咽炎患者是否起效,探讨不同治疗方案、单一和多重过敏、性别等因素是否对SLIT起效有影响。方法:对我院53例螨过敏咽炎患者,进行治疗前和治疗6个月后的药物总评分(TMS)和治疗6个月后的患者自我疗效评价。根据给药方案将试验组分为SLIT组、综合组;根据点刺结果将试验组分为尘螨组和多重组;根据性别将试验组分为男性组和女性组。将25例仅接受对症药物治疗的患者作为对照组。将对照组和试验组以及试验组中不同各组在治疗6个月后的有效率和TMS减少比例进行比较。结果:试验组有效率和TMS减少比均高于对照组,差异有统计学意义(P0.01)。SLIT组有效率为72.73%,综合组为76.47%,两者差异无统计学意义(P0.05);尘螨组有效率和TMS减少比分别为61.54%和94.46%,多重组分别为66.67%和71.25%,2组有效率和TMS减少比比较,差异无统计学意义(P0.05);女性组有效率和TMS减少比分别为83.33%和97.04%,男性组分别为58.33%和66.67%,2组有效率差异无统计学意义(P0.05),而2组TMS减少比差异有统计学意义(P0.05)。结论:SLIT对螨过敏咽炎患者有效;治疗方案,单一和多重过敏对SLIT治疗螨过敏咽炎患者无影响,性别有一定影响。
[Abstract]:Objective: to evaluate whether sublingual specific immunotherapy for (SLIT) mite hypersensitive pharyngitis is effective, and to explore whether different therapeutic schemes, single and multiple allergies, and sex have influence on the SLIT response. Methods: 53 patients with hypersensitive pharyngitis of mite were evaluated by (TMS) before treatment and 6 months after treatment. The experimental group was divided into SLIT group and comprehensive group according to the drug administration scheme, the experimental group was divided into dust mites group and multiple recombination group according to the prick results, and the experimental group was divided into male and female groups according to sex. Twenty-five patients with symptomatic drug therapy were used as control group. The effective rate and the ratio of TMS reduction were compared between the control group and the experimental group and the different groups in the test group after 6 months of treatment. Results: the effective rate and TMS reduction ratio in the experimental group were higher than those in the control group. The difference was statistically significant (P0.01). The effective rate of SLIT group was 72.733.There was no significant difference between the two groups (P0.05), the effective rate and TMS reduction ratio of dust mite group were 61.54% and 94.46%, the effective rate of multiple recombination group were 66.67% and 71.25%, respectively. There was no significant difference (P0.05); the effective rate and TMS reduction ratio were 83.33% and 97.04 in female group, 58.33% and 66.67% in male group, respectively (P0.05), but there was significant difference in TMS reduction ratio between two groups (P0.05). Conclusion the treatment of hypersensitive pharyngitis patients with mites by SLIT is effective, and the single or multiple allergies have no effect on the treatment of hypersensitive pharyngitis by SLIT, and the sex has some influence on the patients with hypersensitive pharyngitis.
【作者单位】: 安徽医科大学附属安庆医院;安庆市立医院耳鼻咽喉科;
【分类号】:R766.14

【参考文献】

相关期刊论文 前7条

1 程静;桂晓钟;;粉尘螨滴剂对3~14岁支气管哮喘和过敏性鼻炎的疗效及安全性分析[J];安徽医药;2009年08期

2 吴建平;梅志丹;陶泽璋;耿惠君;;变态反应性咽炎的诊断和治疗[J];临床耳鼻咽喉科杂志;2006年22期

3 周丽枫;王洁;陈彦球;罗仁忠;陶佳;聂明荣;刘碧霞;李玉云;;舌下含服粉尘螨滴剂治疗多种变应原过敏的变应性鼻炎儿童的疗效与安全性评估[J];临床耳鼻咽喉头颈外科杂志;2012年20期

4 陈建军;孔维佳;项济生;舒宏;施秋梅;檀慧芳;周月;;标准化粉尘螨滴剂治疗变应性鼻炎的半年期疗效及安全性研究[J];华中科技大学学报(医学版);2008年06期

5 吕学仿;马力学;;慢性咽炎的综合治疗[J];人民军医;2012年09期

6 曹兰芳;陆权;顾洪亮;陈燕萍;张源;陆敏;钱耀琴;李岚;许以平;;舌下含服粉尘螨滴剂治疗儿童过敏性哮喘和变应性鼻炎的临床评价[J];中华儿科杂志;2007年10期

7 张宏;;蓝芩口服液对慢性咽炎患者IL-2、TNF-α、免疫细胞亚群及临床症状的改善作用研究[J];现代中西医结合杂志;2013年02期

【共引文献】

相关期刊论文 前10条

1 陈宗鑫;何薇;何莉;;屋尘螨脱敏治疗对变应性鼻炎特异性IgG_4抗体的影响[J];安徽医学;2011年01期

2 黄学勤;程学仕;王俊芳;杨洋;;粉尘螨滴剂治疗变应性鼻炎的临床疗效及安全性观察[J];安徽医药;2010年06期

3 王瑾;吴昊;;特异性免疫治疗变应性支气管哮喘62例疗效观察[J];安徽医药;2011年08期

4 马香萍;多力坤;;舌下特异性免疫治疗对尘螨过敏性哮喘儿童的作用[J];中国当代儿科杂志;2010年05期

5 王晓玲;赵一鸣;;舌下脱敏疗法在儿童过敏性哮喘中的应用[J];儿科药学杂志;2009年06期

6 杨海燕;黄英;;儿童哮喘舌下特异性免疫治疗的疗效及安全性[J];儿科药学杂志;2011年01期

7 王小琴;;粉尘螨滴剂治疗过敏性鼻炎120例疗效分析[J];蚌埠医学院学报;2012年06期

8 杨羿容;朱德姝;徐小鸿;;鼻内镜手术治疗鼻源性慢性咽炎90例临床分析[J];重庆医学;2012年19期

9 郑伯强;王桂兰;杨赛;;粉尘螨滴剂舌下特异性免疫治疗对儿童咳嗽变异性哮喘的有效性[J];中国当代儿科杂志;2012年08期

10 沈f,

本文编号:2156400


资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/yank/2156400.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户cef7b***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com